These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 16227062)
1. Emerging drugs of abuse. Haroz R; Greenberg MI Med Clin North Am; 2005 Nov; 89(6):1259-76. PubMed ID: 16227062 [TBL] [Abstract][Full Text] [Related]
2. New drugs of abuse in North America. Haroz R; Greenberg MI Clin Lab Med; 2006 Mar; 26(1):147-64, ix. PubMed ID: 16567229 [TBL] [Abstract][Full Text] [Related]
3. Poisoning with illicit substances: toxicology for the anaesthetist. Wong GT; Irwin MG Anaesthesia; 2013 Jan; 68 Suppl 1():117-24. PubMed ID: 23210561 [TBL] [Abstract][Full Text] [Related]
8. Nephrotoxicity of BZP-based herbal party pills: a New Zealand case report. Alansari M; Hamilton D N Z Med J; 2006 May; 119(1233):U1959. PubMed ID: 16680176 [No Abstract] [Full Text] [Related]
9. Fatal poisoning in the region of Epirus, Greece, during the period 1998-2004. Vougiouklakis T; Boumba VA; Mitselou A J Clin Forensic Med; 2006; 13(6-8):321-5. PubMed ID: 17023191 [TBL] [Abstract][Full Text] [Related]
10. [A multicenter survey of poisoning after consumption of products containing synthetic chemicals in Japan]. Kamijo Y Chudoku Kenkyu; 2014 Sep; 27(3):227-9. PubMed ID: 27526519 [No Abstract] [Full Text] [Related]
11. Fatal zipeprol and dextromethorphan poisonings in Korea. Yoo Y; Chung H; Kim E; Kim M J Anal Toxicol; 1996; 20(3):155-8. PubMed ID: 8735195 [TBL] [Abstract][Full Text] [Related]
12. Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part II--piperazines/piperidines, phenylethylamines, tryptamines and miscellaneous 'others'. Biliński P; Hołownia P; Kapka-Skrzypczak L; Wojtyła A Ann Agric Environ Med; 2012; 19(4):871-82. PubMed ID: 23311821 [TBL] [Abstract][Full Text] [Related]
13. Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type. Paulozzi LJ; Xi Y Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):997-1005. PubMed ID: 18512264 [TBL] [Abstract][Full Text] [Related]
14. Research chemicals marketed as legal highs: the case of pipradrol derivatives. Coppola M; Mondola R Toxicol Lett; 2012 Jul; 212(1):57-60. PubMed ID: 22564760 [TBL] [Abstract][Full Text] [Related]
15. Methylone and mCPP, two new drugs of abuse? Bossong MG; Van Dijk JP; Niesink RJ Addict Biol; 2005 Dec; 10(4):321-3. PubMed ID: 16318952 [TBL] [Abstract][Full Text] [Related]
16. Benzylpiperazine: a drug of abuse? Johnstone AC; Lea RA; Brennan KA; Schenk S; Kennedy MA; Fitzmaurice PS J Psychopharmacol; 2007 Nov; 21(8):888-94. PubMed ID: 17606471 [TBL] [Abstract][Full Text] [Related]
18. Risk evaluation and mitigation strategies for drugs with abuse liability: public interest, special interest, conflicts of interest, and the industry perspective. Wright C; Schnoll S; Bernstein D Ann N Y Acad Sci; 2008 Oct; 1141():284-303. PubMed ID: 18991964 [TBL] [Abstract][Full Text] [Related]
19. Generation next: club drugs. Curran R Emerg Med Serv; 2004 Oct; 33(10):107-8, 110-2, 119. PubMed ID: 15553531 [No Abstract] [Full Text] [Related]
20. Foxy methoxy: a new drug of abuse. Smolinske SC; Rastogi R; Schenkel S J Med Toxicol; 2005 Dec; 1(1):22-5. PubMed ID: 18072099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]